Ligand validation:6DZF

XYS: alpha-D-xylopyranose

XYS is a Ligand Of Interest in 6DZF designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6DZF_XYS_A_304	5%	29%	0.385	0.782	1.82	1.17	1	2	0	0	100%	1
6B6Q_XYS_A_306	63%	43%	0.13	0.925	1.65	0.64	1	-	0	0	100%	1
6B6P_XYS_A_306	35%	39%	0.188	0.878	1.46	1.02	1	2	0	0	100%	1
6AVL_XYS_A_305	10%	38%	0.23	0.735	1.81	0.72	1	-	0	0	100%	0.78
6B6O_XYS_A_306	2%	38%	0.357	0.63	1.6	0.89	1	-	0	0	100%	1
5A03_XYS_B_1342	92%	35%	0.063	0.953	1.68	1.01	1	1	0	0	100%	1
8OZ1_XYS_A_804	91%	61%	0.064	0.967	0.83	0.66	-	-	0	0	90%	0.9
8BQA_XYS_AAA_402	88%	36%	0.058	0.951	0.83	1.77	-	3	0	0	90%	0.9
7PLC_XYS_C_302	85%	62%	0.096	0.961	0.55	0.87	-	1	1	0	100%	1
2CDC_XYS_D_1371	82%	48%	0.1	0.954	1.01	0.99	1	1	0	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.